|
⚲
|
| Keyboard |
| Gay Robert C
✚
|
|
|---|---|
| CIK # | 0001032566 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001032566] | |
| 4 | [0001032566] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Gay Robert C | |
| Southport Acquisition Corp | |
| Merrimack Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Southport Acquisition Corp ANGX
Restricted Stock Units · derivative
|
2025-10-23 | Grant | 10,593 | ||
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-03 | Conversion | 175,316 | ||
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-03 | Conversion | 142,857 | ||
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-03 | Conversion | 142,857 | ||
|
Merrimack Pharmaceuticals Inc MACK
Common Stock
|
2012-04-03 | Conversion | 175,316 | ||
|
Merrimack Pharmaceuticals Inc MACK
Series B Convertible Preferred Stock · derivative
|
2012-04-03 | Conversion | 113,586 | $0.00 | |
|
Merrimack Pharmaceuticals Inc MACK
Series D Convertible Preferred Stock · derivative
|
2012-04-03 | Conversion | 142,857 | $0.00 | |
|
Merrimack Pharmaceuticals Inc MACK
Series D Convertible Preferred Stock · derivative
|
2012-04-03 | Conversion | 142,857 | $0.00 | |
|
Merrimack Pharmaceuticals Inc MACK
Series B Convertible Preferred Stock · derivative
|
2012-04-03 | Conversion | 113,586 | $0.00 |